Dr Cohen reviews his presentation from the July 25 AIBD regional meeting on using biosimilars as first-line and switch therapy in patients with inflammatory bowel disease.
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.
In this video, Cindy Cooke, DNP, gives a preview of a new session type at our Practical Updates in Primary Care 2021 Virtual Series, in which the co-chairs present challenging case studies and discuss the...
Paul J. Pockros, MD, assesses the use and limitations of triple therapy in specific patient populations such as patients with cirrhosis, transplant recipients, and patients who are coinfected with HIV.
...
